HOXA9 and central nervous system cancer: Additionally, miR-638 directly targets the HOXA9 3’UTR, suppresses HOXA9 expression, and inhibits the two Wnt signaling effectors c-Myc and Cyclin D1, whereas overexpression of HOXA9 can partially counteract the effects of miR-638 in glioma.